Literature DB >> 18160569

Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass grafting.

Brian R Untch1, Walter P Jeske, Jeffrey Schwartz, Sally Botkin, Margaret Prechel, Jeanine M Walenga, Mamdouh Bakhos.   

Abstract

To characterize hemostatic differences imposed by 2 common cardiac surgeries, the authors studied patients undergoing coronary artery revascularization by off-pump (n = 13) or cardiopulmonary bypass on-pump (n = 26) technique. Blood samples collected to 4 days post-surgery were evaluated by flow cytometry and enzyme-linked immunosorbent assay. A significant inflammatory response occurred in both the groups after surgery shown by increased interleukin cytokines and C-reactive protein; however, levels peaked lower and hours later in the off-pump group. Platelets (P-selectin; platelet-leukocyte complexes) and leukocytes (CD11b) were activated only in on-pump patients. Thrombin generation was enhanced in both groups after surgery. Only in the on-pump patients, the thrombin-antithrombin complex, pro-thrombin fragment 1.2, and thrombomodulin (vascular integrity) decreased intraoperatively. Tissue plasminogen activator and plasminogen activator inhibitor-1 were greater in the on-pump patients. Off-pump surgery may place patients at higher risk of postoperative hypercoagulability because of normal platelet function, intraoperative thrombin generation, less fibrinolytic activity, and lack of vascular protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160569     DOI: 10.1177/1076029607308869

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  2 in total

Review 1.  Meta-analysis of interleukin 6, 8, and 10 between off-pump and on-pump coronary artery bypass groups.

Authors:  Fanbo Meng; Jianghong Ma; Wei Wang; Baisong Lin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

2.  PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass.

Authors:  Agnese Ozolina; Eva Strike; Inta Jaunalksne; Angelika Krumina; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2012-10-30       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.